Onderneming Nexstim Oyj Nasdaq Helsinki
Aandelen
NXTMH
FI4000102678
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Navigated Brain Stimulation Systems
42,9
%
| 2 | 23,6 % | 3 | 42,9 % | +38,51% |
Navigated Brain Therapy Systems Continuous
27,4
%
| 2 | 18,3 % | 2 | 27,4 % | +13,58% |
Navigated Brain Stimulation Systems Continuous
16,3
%
| 1 | 12,3 % | 1 | 16,3 % | +0,52% |
Navigated Brain Therapy Systems
13,4
%
| 1 | 8,7 % | 1 | 13,4 % | +17,69% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
44,8
%
| 6 | 64,2 % | 3 | 44,8 % | -46,88% |
Rest of Europe
30,9
%
| 1 | 14,4 % | 2 | 30,9 % | +63,57% |
Finland
20,6
%
| 2 | 18,9 % | 1 | 20,6 % | -17,07% |
Other
3,6
%
| 0 | 2,5 % | 0 | 3,6 % | +8,90% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 47 | 18-08-14 | |
Director of Finance/CFO | 38 | 01-05-14 | |
Gustaf Järnefelt
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-08 |
Jarmo Laine
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-08 |
Hanna Kotola
LAW | General Counsel | - | 01-06-17 |
Henri Hannula
SAM | Sales & Marketing | 50 | 01-01-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 62 | 11-11-19 | |
Director/Board Member | 53 | 01-05-21 | |
Director/Board Member | 65 | 01-05-21 | |
Chairman | 61 | 11-11-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 6 765 562 | 3 462 766 ( 51,18 %) | 0 | 51,18 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,84% | 218 mld. | |
+7,35% | 184 mld. | |
+13,04% | 135 mld. | |
+26,03% | 107 mld. | |
-1,33% | 62,38 mld. | |
+11,80% | 51,37 mld. | |
+4,81% | 50,9 mld. | |
+0,30% | 40,87 mld. | |
+2,78% | 36,28 mld. |